Imatge de la portada

Convalescent Plasma and Other Antibody Therapies for Infectious Diseases Lessons learned from COVID-19 and Future Prospects /

This volume reviews key scientific principles and practices of passive antibody therapy for the treatment of infectious diseases. The main focus is on convalescent plasma, which is the most useful therapeutic option early in an epidemic, and may be especially important in low- and middle-income coun...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor corporatiu: SpringerLink (Online service)
Altres autors: Paneth, Nigel (Editor), Joyner, Michael J. (Editor), Casadevall, Arturo (Editor)
Format: Electrònic eBook
Idioma:anglès
Publicat: Cham : Springer Nature Switzerland : Imprint: Springer, 2025.
Edició:1st ed. 2025.
Col·lecció:Current Topics in Microbiology and Immunology, 443
Matèries:
Immunology.
Medical microbiology.
Pharmacology.
Virology.
Applied Immunology.
Medical Microbiology.
Accés en línia:https://doi.org/10.1007/978-3-031-87167-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
Taula de continguts:
  • THE LOGIC AND HISTORY OF PASSIVE IMMUNITY AND ANTIBODY THERAPIES
  • A BRIEF HISTORY OF POLYCLONAL ANTIBODY THERAPIES AGAINST BACTERIAL AND VIRAL DISEASES BEFORE COVID-19
  • THE IMPORTANCE OF ANTIBODY TITER DETERMINATION TO THE EFFECTIVE USE OF CONVALESCENT PLASMA
  • CONVALESCENT PLASMA AND THE US EXPANDED ACCESS PROGRAM: A PERSONAL NARRATIVE
  • The safety profile of COVID-19 convalescent plasma
  • The Importance of Geographic Proximity of Convalescent Plasma Donors
  • Evidence for the efficacy of COVID-19 convalescent plasma
  • CONVALESCENT PLASMA FOR IMMUNOCOMPROMISED PATIENTS
  • MONOCLONAL ANTIBODY THERAPIES AGAINST SARS-CoV-2: PROMISES AND REALITIES
  • Hyperimmune Globulins in COVID-19
  • THE ROLE OF THE PATIENT ADVOCATE DURING A PANDEMIC: THE CASE OF CONVALESCENT PLASMA
  • BLOOD BANKING CAPACITY IN LOW-AND MIDDLE-INCOME COUNTRIES: COVID-19 CONVALESCENT PLASMA IN CONTEXT
  • HEMOCLEAR: A PRACTICAL AND COST-EFFECTIVE ALTERNATIVE TO CONVENTIONAL CONVALESCENT PLASMA RETRIEVAL METHODS
  • GENERATING THE EVIDENCE BASE FOR CONVALESCENT PLASMA USE FOR A NEW INFECTIOUS DISEASE
  • CONVALESCENT PLASMA AND OTHER ANTIBODY THERAPIES FOR INFECTIOUS DISEASES – LESSONS LEARNED FROM COVID-19 AND FUTURE PROSPECTS
  • MONOCLONAL ANTIBODIES AND HYPERIMMUNE IMMUNOGLOBULINS IN THE NEXT PANDEMIC
  • USING PASSIVE ANTIBODY THERAPIES IN THE NEXT PANDEMIC.

Ítems similars